Copyright Reports & Markets. All rights reserved.

Global OTC Anti-Infective Products Sales Market Report 2021

Request for Sample of this report
Buy now

1 OTC Anti-Infective Products Market Overview

  • 1.1 OTC Anti-Infective Products Product Scope
  • 1.2 OTC Anti-Infective Products Segment by Type
    • 1.2.1 Global OTC Anti-Infective Products Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Antifungals
    • 1.2.3 Antiseptic
    • 1.2.4 Antiparasitics
  • 1.3 OTC Anti-Infective Products Segment by Application
    • 1.3.1 Global OTC Anti-Infective Products Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Drug Stores
    • 1.3.4 Retail Stores
    • 1.3.5 E-Commerce
  • 1.4 OTC Anti-Infective Products Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global OTC Anti-Infective Products Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global OTC Anti-Infective Products Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global OTC Anti-Infective Products Price Trends (2016-2027)

2 OTC Anti-Infective Products Estimates and Forecasts by Region

  • 2.1 Global OTC Anti-Infective Products Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global OTC Anti-Infective Products Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
    • 2.2.2 Global OTC Anti-Infective Products Revenue Market Share by Region (2016-2021)
  • 2.3 Global OTC Anti-Infective Products Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global OTC Anti-Infective Products Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global OTC Anti-Infective Products Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America OTC Anti-Infective Products Estimates and Projections (2016-2027)
    • 2.4.2 Europe OTC Anti-Infective Products Estimates and Projections (2016-2027)
    • 2.4.3 China OTC Anti-Infective Products Estimates and Projections (2016-2027)
    • 2.4.4 Japan OTC Anti-Infective Products Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia OTC Anti-Infective Products Estimates and Projections (2016-2027)
    • 2.4.6 India OTC Anti-Infective Products Estimates and Projections (2016-2027)

3 Global OTC Anti-Infective Products Competition Landscape by Players

  • 3.1 Global Top OTC Anti-Infective Products Players by Sales (2016-2021)
  • 3.2 Global Top OTC Anti-Infective Products Players by Revenue (2016-2021)
  • 3.3 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in OTC Anti-Infective Products as of 2020)
  • 3.4 Global OTC Anti-Infective Products Average Price by Company (2016-2021)
  • 3.5 Manufacturers OTC Anti-Infective Products Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global OTC Anti-Infective Products Market Size by Type

  • 4.1 Global OTC Anti-Infective Products Historic Market Review by Type (2016-2021)
    • 4.1.1 Global OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
    • 4.1.2 Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global OTC Anti-Infective Products Price by Type (2016-2021)
  • 4.2 Global OTC Anti-Infective Products Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2022-2027)
    • 4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global OTC Anti-Infective Products Price Forecast by Type (2022-2027)

5 Global OTC Anti-Infective Products Market Size by Application

  • 5.1 Global OTC Anti-Infective Products Historic Market Review by Application (2016-2021)
    • 5.1.1 Global OTC Anti-Infective Products Sales Market Share by Application (2016-2021)
    • 5.1.2 Global OTC Anti-Infective Products Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global OTC Anti-Infective Products Price by Application (2016-2021)
  • 5.2 Global OTC Anti-Infective Products Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2022-2027)
    • 5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2022-2027)

6 North America OTC Anti-Infective Products Market Facts & Figures

  • 6.1 North America OTC Anti-Infective Products Sales by Company
    • 6.1.1 North America OTC Anti-Infective Products Sales by Company (2016-2021)
    • 6.1.2 North America OTC Anti-Infective Products Revenue by Company (2016-2021)
  • 6.2 North America OTC Anti-Infective Products Sales Breakdown by Type
    • 6.2.1 North America OTC Anti-Infective Products Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America OTC Anti-Infective Products Sales Breakdown by Type (2022-2027)
  • 6.3 North America OTC Anti-Infective Products Sales Breakdown by Application
    • 6.3.1 North America OTC Anti-Infective Products Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America OTC Anti-Infective Products Sales Breakdown by Application (2022-2027)

7 Europe OTC Anti-Infective Products Market Facts & Figures

  • 7.1 Europe OTC Anti-Infective Products Sales by Company
    • 7.1.1 Europe OTC Anti-Infective Products Sales by Company (2016-2021)
    • 7.1.2 Europe OTC Anti-Infective Products Revenue by Company (2016-2021)
  • 7.2 Europe OTC Anti-Infective Products Sales Breakdown by Type
    • 7.2.1 Europe OTC Anti-Infective Products Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe OTC Anti-Infective Products Sales Breakdown by Type (2022-2027)
  • 7.3 Europe OTC Anti-Infective Products Sales Breakdown by Application
    • 7.3.1 Europe 141 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 141 Sales Breakdown by Application (2022-2027)

8 China OTC Anti-Infective Products Market Facts & Figures

  • 8.1 China OTC Anti-Infective Products Sales by Company
    • 8.1.1 China OTC Anti-Infective Products Sales by Company (2016-2021)
    • 8.1.2 China OTC Anti-Infective Products Revenue by Company (2016-2021)
  • 8.2 China OTC Anti-Infective Products Sales Breakdown by Type
    • 8.2.1 China OTC Anti-Infective Products Sales Breakdown by Type (2016-2021)
    • 8.2.2 China OTC Anti-Infective Products Sales Breakdown by Type (2022-2027)
  • 8.3 China OTC Anti-Infective Products Sales Breakdown by Application
    • 8.3.1 China 310 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 310 Sales Breakdown by Application (2022-2027)

9 Japan OTC Anti-Infective Products Market Facts & Figures

  • 9.1 Japan OTC Anti-Infective Products Sales by Company
    • 9.1.1 Japan OTC Anti-Infective Products Sales by Company (2016-2021)
    • 9.1.2 Japan OTC Anti-Infective Products Revenue by Company (2016-2021)
  • 9.2 Japan OTC Anti-Infective Products Sales Breakdown by Type
    • 9.2.1 Japan OTC Anti-Infective Products Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan OTC Anti-Infective Products Sales Breakdown by Type (2022-2027)
  • 9.3 Japan OTC Anti-Infective Products Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia OTC Anti-Infective Products Market Facts & Figures

  • 10.1 Southeast Asia OTC Anti-Infective Products Sales by Company
    • 10.1.1 Southeast Asia OTC Anti-Infective Products Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia OTC Anti-Infective Products Revenue by Company (2016-2021)
  • 10.2 Southeast Asia OTC Anti-Infective Products Sales Breakdown by Type
    • 10.2.1 Southeast Asia OTC Anti-Infective Products Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia OTC Anti-Infective Products Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia OTC Anti-Infective Products Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India OTC Anti-Infective Products Market Facts & Figures

  • 11.1 India OTC Anti-Infective Products Sales by Company
    • 11.1.1 India OTC Anti-Infective Products Sales by Company (2016-2021)
    • 11.1.2 India OTC Anti-Infective Products Revenue by Company (2016-2021)
  • 11.2 India OTC Anti-Infective Products Sales Breakdown by Type
    • 11.2.1 India OTC Anti-Infective Products Sales Breakdown by Type (2016-2021)
    • 11.2.2 India OTC Anti-Infective Products Sales Breakdown by Type (2022-2027)
  • 11.3 India OTC Anti-Infective Products Sales Breakdown by Application
    • 11.3.1 India OTC Anti-Infective Products Sales Breakdown by Application (2016-2021)
    • 11.3.2 India OTC Anti-Infective Products Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in OTC Anti-Infective Products Business

  • 12.1 GlaxoSmithKline
    • 12.1.1 GlaxoSmithKline Corporation Information
    • 12.1.2 GlaxoSmithKline Business Overview
    • 12.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
    • 12.1.5 GlaxoSmithKline Recent Development
  • 12.2 Merck
    • 12.2.1 Merck Corporation Information
    • 12.2.2 Merck Business Overview
    • 12.2.3 Merck OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Merck OTC Anti-Infective Products Products Offered
    • 12.2.5 Merck Recent Development
  • 12.3 Pfizer
    • 12.3.1 Pfizer Corporation Information
    • 12.3.2 Pfizer Business Overview
    • 12.3.3 Pfizer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Pfizer OTC Anti-Infective Products Products Offered
    • 12.3.5 Pfizer Recent Development
  • 12.4 Novartis
    • 12.4.1 Novartis Corporation Information
    • 12.4.2 Novartis Business Overview
    • 12.4.3 Novartis OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Novartis OTC Anti-Infective Products Products Offered
    • 12.4.5 Novartis Recent Development
  • 12.5 Abbott
    • 12.5.1 Abbott Corporation Information
    • 12.5.2 Abbott Business Overview
    • 12.5.3 Abbott OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Abbott OTC Anti-Infective Products Products Offered
    • 12.5.5 Abbott Recent Development
  • 12.6 Sanofi
    • 12.6.1 Sanofi Corporation Information
    • 12.6.2 Sanofi Business Overview
    • 12.6.3 Sanofi OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Sanofi OTC Anti-Infective Products Products Offered
    • 12.6.5 Sanofi Recent Development
  • 12.7 Bristol-Myers Squibb
    • 12.7.1 Bristol-Myers Squibb Corporation Information
    • 12.7.2 Bristol-Myers Squibb Business Overview
    • 12.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
    • 12.7.5 Bristol-Myers Squibb Recent Development
  • 12.8 Roche
    • 12.8.1 Roche Corporation Information
    • 12.8.2 Roche Business Overview
    • 12.8.3 Roche OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Roche OTC Anti-Infective Products Products Offered
    • 12.8.5 Roche Recent Development
  • 12.9 NanoViricides
    • 12.9.1 NanoViricides Corporation Information
    • 12.9.2 NanoViricides Business Overview
    • 12.9.3 NanoViricides OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 NanoViricides OTC Anti-Infective Products Products Offered
    • 12.9.5 NanoViricides Recent Development
  • 12.10 Novabay Pharmaceuticals
    • 12.10.1 Novabay Pharmaceuticals Corporation Information
    • 12.10.2 Novabay Pharmaceuticals Business Overview
    • 12.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
    • 12.10.5 Novabay Pharmaceuticals Recent Development
  • 12.11 Optimer Pharmaceuticals
    • 12.11.1 Optimer Pharmaceuticals Corporation Information
    • 12.11.2 Optimer Pharmaceuticals Business Overview
    • 12.11.3 Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Optimer Pharmaceuticals OTC Anti-Infective Products Products Offered
    • 12.11.5 Optimer Pharmaceuticals Recent Development
  • 12.12 Basilea Pharmaceutica
    • 12.12.1 Basilea Pharmaceutica Corporation Information
    • 12.12.2 Basilea Pharmaceutica Business Overview
    • 12.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Basilea Pharmaceutica OTC Anti-Infective Products Products Offered
    • 12.12.5 Basilea Pharmaceutica Recent Development
  • 12.13 MerLion Pharma
    • 12.13.1 MerLion Pharma Corporation Information
    • 12.13.2 MerLion Pharma Business Overview
    • 12.13.3 MerLion Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 MerLion Pharma OTC Anti-Infective Products Products Offered
    • 12.13.5 MerLion Pharma Recent Development

13 OTC Anti-Infective Products Manufacturing Cost Analysis

  • 13.1 OTC Anti-Infective Products Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of OTC Anti-Infective Products
  • 13.4 OTC Anti-Infective Products Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 OTC Anti-Infective Products Distributors List
  • 14.3 OTC Anti-Infective Products Customers

15 Market Dynamics

  • 15.1 OTC Anti-Infective Products Market Trends
  • 15.2 OTC Anti-Infective Products Drivers
  • 15.3 OTC Anti-Infective Products Market Challenges
  • 15.4 OTC Anti-Infective Products Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global OTC Anti-Infective Products market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OTC Anti-Infective Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Antifungals
    Antiseptic
    Antiparasitics

    Segment by Application
    Hospital Pharmacies
    Drug Stores
    Retail Stores
    E-Commerce

    The OTC Anti-Infective Products market is analysed and market size information is provided by regions (countries). Segment by Application, the OTC Anti-Infective Products market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis
    Abbott
    Sanofi
    Bristol-Myers Squibb
    Roche
    NanoViricides
    Novabay Pharmaceuticals
    Optimer Pharmaceuticals
    Basilea Pharmaceutica
    MerLion Pharma

    Buy now